| Views | |
|---|---|
| Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19 | 29 |
| October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19 | 0 | 0 | 1 | 1 | 0 | 0 | 1 |
| Views | |
|---|---|
| dic.2022-1-1.pdf | 30 |
| Views | |
|---|---|
| United States | 12 |
| Russia | 10 |
| Canada | 2 |
| Germany | 2 |
| Belarus | 1 |
| Views | |
|---|---|
| Moscow | 5 |
| Andover | 3 |
| Menlo Park | 3 |
| Ottawa | 2 |
| Houston | 1 |
| Vitebsk | 1 |